Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1999 1
2002 1
2003 1
2005 1
2006 1
2007 1
2008 1
2009 1
2010 2
2011 2
2012 2
2013 1
2014 6
2015 6
2016 6
2017 8
2018 7
2019 9
2020 5
2021 6
2022 12
2023 16
2024 12

Text availability

Article attribute

Article type

Publication date

Search Results

93 results

Results by year

Filters applied: . Clear all
Page 1
Clinical Practice Guideline for the Evaluation and Treatment of Children and Adolescents With Obesity.
Hampl SE, Hassink SG, Skinner AC, Armstrong SC, Barlow SE, Bolling CF, Avila Edwards KC, Eneli I, Hamre R, Joseph MM, Lunsford D, Mendonca E, Michalsky MP, Mirza N, Ochoa ER, Sharifi M, Staiano AE, Weedn AE, Flinn SK, Lindros J, Okechukwu K. Hampl SE, et al. Among authors: bolling cf. Pediatrics. 2023 Feb 1;151(2):e2022060640. doi: 10.1542/peds.2022-060640. Pediatrics. 2023. PMID: 36622115 No abstract available.
Preventing Obesity and Eating Disorders in Adolescents.
Golden NH, Schneider M, Wood C; COMMITTEE ON NUTRITION; COMMITTEE ON ADOLESCENCE; SECTION ON OBESITY. Golden NH, et al. Pediatrics. 2016 Sep;138(3):e20161649. doi: 10.1542/peds.2016-1649. Epub 2016 Aug 22. Pediatrics. 2016. PMID: 27550979 Review.
Return to sports after ACL injury 5 years from now: 10 things we must do.
Gokeler A, Grassi A, Hoogeslag R, van Houten A, Lehman T, Bolling C, Buckthorpe M, Norte G, Benjaminse A, Heuvelmans P, Di Paolo S, Tak I, Villa FD. Gokeler A, et al. Among authors: bolling c. J Exp Orthop. 2022 Jul 30;9(1):73. doi: 10.1186/s40634-022-00514-7. J Exp Orthop. 2022. PMID: 35907095 Free PMC article. Review.
Ramucirumab versus placebo in combination with second-line FOLFIRI in patients with metastatic colorectal carcinoma that progressed during or after first-line therapy with bevacizumab, oxaliplatin, and a fluoropyrimidine (RAISE): a randomised, double-blind, multicentre, phase 3 study.
Tabernero J, Yoshino T, Cohn AL, Obermannova R, Bodoky G, Garcia-Carbonero R, Ciuleanu TE, Portnoy DC, Van Cutsem E, Grothey A, Prausová J, Garcia-Alfonso P, Yamazaki K, Clingan PR, Lonardi S, Kim TW, Simms L, Chang SC, Nasroulah F; RAISE Study Investigators. Tabernero J, et al. Lancet Oncol. 2015 May;16(5):499-508. doi: 10.1016/S1470-2045(15)70127-0. Epub 2015 Apr 12. Lancet Oncol. 2015. PMID: 25877855 Clinical Trial.
Executive Summary: Clinical Practice Guideline for the Evaluation and Treatment of Children and Adolescents With Obesity.
Hampl SE, Hassink SG, Skinner AC, Armstrong SC, Barlow SE, Bolling CF, Avila Edwards KC, Eneli I, Hamre R, Joseph MM, Lunsford D, Mendonca E, Michalsky MP, Mirza N, Ochoa ER, Sharifi M, Staiano AE, Weedn AE, Flinn SK, Lindros J, Okechukwu K. Hampl SE, et al. Among authors: bolling cf. Pediatrics. 2023 Feb 1;151(2):e2022060641. doi: 10.1542/peds.2022-060641. Pediatrics. 2023. PMID: 36622135 No abstract available.
Addition of isatuximab to lenalidomide, bortezomib, and dexamethasone as induction therapy for newly diagnosed, transplantation-eligible patients with multiple myeloma (GMMG-HD7): part 1 of an open-label, multicentre, randomised, active-controlled, phase 3 trial.
Goldschmidt H, Mai EK, Bertsch U, Fenk R, Nievergall E, Tichy D, Besemer B, Dürig J, Schroers R, von Metzler I, Hänel M, Mann C, Asemissen AM, Heilmeier B, Weinhold N, Huhn S, Kriegsmann K, Luntz SP, Holderried TAW, Trautmann-Grill K, Gezer D, Klaiber-Hakimi M, Müller M, Khandanpour C, Knauf W, Scheid C, Munder M, Geer T, Riesenberg H, Thomalla J, Hoffmann M, Raab MS, Salwender HJ, Weisel KC; German-Speaking Myeloma Multicenter Group (GMMG) HD7 investigators. Goldschmidt H, et al. Lancet Haematol. 2022 Nov;9(11):e810-e821. doi: 10.1016/S2352-3026(22)00263-0. Lancet Haematol. 2022. PMID: 36328040 Clinical Trial.
Athlete health protection: Why qualitative research matters.
Bekker S, Bolling C, H Ahmed O, Badenhorst M, Carmichael J, Fagher K, Hägglund M, Jacobsson J, John JM, Litzy K, H Mann R, D McKay C, Mumford S, Tabben M, Thiel A, Timpka T, Thurston J, Truong LK, Spörri J, van Nassau F, Verhagen EA. Bekker S, et al. Among authors: bolling c. J Sci Med Sport. 2020 Oct;23(10):898-901. doi: 10.1016/j.jsams.2020.06.020. Epub 2020 Jul 3. J Sci Med Sport. 2020. PMID: 32665215 No abstract available.
Perioperative Atezolizumab Plus Fluorouracil, Leucovorin, Oxaliplatin, and Docetaxel for Resectable Esophagogastric Cancer: Interim Results From the Randomized, Multicenter, Phase II/III DANTE/IKF-s633 Trial.
Lorenzen S, Götze TO, Thuss-Patience P, Biebl M, Homann N, Schenk M, Lindig U, Heuer V, Kretzschmar A, Goekkurt E, Haag GM, Riera-Knorrenschild J, Bolling C, Hofheinz RD, Zhan T, Angermeier S, Ettrich TJ, Siebenhuener AR, Elshafei M, Bechstein WO, Gaiser T, Loose M, Sookthai D, Kopp C, Pauligk C, Al-Batran SE; AIO and SAKK Study Working Groups. Lorenzen S, et al. Among authors: bolling c. J Clin Oncol. 2024 Feb 1;42(4):410-420. doi: 10.1200/JCO.23.00975. Epub 2023 Nov 14. J Clin Oncol. 2024. PMID: 37963317 Clinical Trial.
93 results